[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.92.239. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1981

Cytomegalovirus in the Perinatal Period

Author Affiliations

From the Department of Pediatrics, University of Massachusetts Medical School, Worcester.

Am J Dis Child. 1981;135(1):56-60. doi:10.1001/archpedi.1981.02130250044014
Abstract

Cytomegalovirus (CMV) is the most frequent known cause of perinatally acquired infections. Congenital acquisition occurs in 0.5% to 2.7%1-3 and natal acquisition occurs in 4% to 10%3,4 of all deliveries. More than 90% of congenitally and natally acquired CMV infections are subclinical. Of infants infected in utero, a substantial percentage have late neurologic sequelae, such as decreased mentation and auditory impairment.2,3 Not enough studies exist to permit an accurate prediction of eventual outcome among these infants. Nevertheless, CMV is rapidly emerging as the infectious agent most frequently responsible for congenital abnormalities.

HISTORY  The first human strains of CMV were isolated in 1955 by Smith,5 from autopsy material of two infants described by Rowe et al,6 and by Weller and associates, who isolated the virus from hepatic tissue and/or urine of three living infants with cytomegalic inclusion disease (CID).7 Prior to this time, CID was

First Page Preview View Large
First page PDF preview
First page PDF preview
×